Endocrine treatment in breast cancer: cure, resistance and beyond von Tryfonidis, Konstantinos, Zardavas, Dimitrios, Katzenellenbogen, Benita S, Piccart, Martine

Volltext

Anti-angiogenic treatment in breast cancer: facts, successes, failures and future perspectives von Aalders, Kim C, Tryfonidis, Konstantinos, Senkus, Elżbieta, Cardoso, Fatima

Volltext

Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials von Ghislain, Irina, MS, Zikos, Efstathios, MS, Coens, Corneel, MS, Quinten, Chantal, MS, Balta, Vasiliki, MS, Tryfonidis, Konstantinos, MD, Piccart, Martine, Prof, Zardavas, Dimitrios, MD, Nagele, Eva, PhD, Bjelic-Radisic, Vesna, Prof, Cardoso, Fatima, MD, Sprangers, Mirjam A G, Prof, Velikova, Galina, Prof, Bottomley, Andrew, PhD

Volltext

The past and future of breast cancer treatment-from the papyrus to individualised treatment approaches von Ades, Felipe, Tryfonidis, Konstantinos, Zardavas, Dimitrios

Volltext

Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial von Ignatiadis, Michail, Rack, Brigitte, Rothé, Francoise, Riethdorf, Sabine, Decraene, Charles, Bonnefoi, Hervé, Dittrich, Christian, Messina, Carlo, Beauvois, Melanie, Trapp, Elisabeth, Goulioti, Theodora, Tryfonidis, Konstantinos, Pantel, Klaus, Repollet, Madeline, Janni, Wolfgang, Piccart, Martine, Sotiriou, Christos, Litiere, Saskia, Pierga, Jean-Yves

Volltext

Immunotherapy for hormone receptor‒positive HER2-negative breast cancer von Cardoso, Fatima, Hirshfield, Kim M., Kraynyak, Kimberly A., Tryfonidis, Konstantinos, Bardia, Aditya

Volltext

A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers von Monberg, Matthew J., Keefe, Steve, Karantza, Vassiliki, Tryfonidis, Konstantinos, Toker, Sarper, Mejia, Jaime, Orlowski, Robert, Haiderali, Amin, Prabhu, Vimalanand S., Aktan, Gursel

Volltext

Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers von Hilbers, Florentine S., Poncet, Coralie, Tryfonidis, Konstantinos, Viale, Giuseppe, Delaloge, Suzette, Pierga, Jean-Yves, Brain, Etienne G. C., Rubio, Isabel T., Thompson, Alastair M., Rutgers, Emiel J. T., Piccart, Martine J., van ’t Veer, Laura J., Cardoso, Fatima

Volltext

From bench to clinical trials the EORTC experience in biology-based clinical cancer research von Tryfonidis, Konstantinos, Hartmann, Katherine, Morfouace, Marie, Lacombe, Denis

Volltext

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer von Schmid, Peter, Cortes, Javier, Dent, Rebecca, Pusztai, Lajos, McArthur, Heather, Kümmel, Sherko, Bergh, Jonas, Denkert, Carsten, Park, Yeon Hee, Hui, Rina, Harbeck, Nadia, Takahashi, Masato, Untch, Michael, Fasching, Peter A, Cardoso, Fatima, Andersen, Jay, Patt, Debra, Danso, Michael, Ferreira, Marta, Mouret-Reynier, Marie-Ange, Im, Seock-Ah, Ahn, Jin-Hee, Gion, Maria, Baron-Hay, Sally, Boileau, Jean-François, Ding, Yu, Tryfonidis, Konstantinos, Aktan, Gursel, Karantza, Vassiliki, O’Shaughnessy, Joyce

Volltext

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer von Cardoso, Fatima, van’t Veer, Laura J, Bogaerts, Jan, Slaets, Leen, Viale, Giuseppe, Delaloge, Suzette, Pierga, Jean-Yves, Brain, Etienne, Causeret, Sylvain, DeLorenzi, Mauro, Glas, Annuska M, Golfinopoulos, Vassilis, Goulioti, Theodora, Knox, Susan, Matos, Erika, Meulemans, Bart, Neijenhuis, Peter A, Nitz, Ulrike, Passalacqua, Rodolfo, Ravdin, Peter, Rubio, Isabel T, Saghatchian, Mahasti, Smilde, Tineke J, Sotiriou, Christos, Stork, Lisette, Straehle, Carolyn, Thomas, Geraldine, Thompson, Alastair M, van der Hoeven, Jacobus M, Vuylsteke, Peter, Bernards, René, Tryfonidis, Konstantinos, Rutgers, Emiel, Piccart, Martine

Volltext

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, ph... von Wildiers, Hans, Tryfonidis, Konstantinos, Dal Lago, Lissandra, Vuylsteke, Peter, Curigliano, Giuseppe, Waters, Simon, Brouwers, Barbara, Altintas, Sevilay, Touati, Nathan, Cardoso, Fatima, Brain, Etienne

Volltext

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age von Piccart, Martine, van 't Veer, Laura J, Poncet, Coralie, Lopes Cardozo, Josephine M N, Delaloge, Suzette, Pierga, Jean-Yves, Vuylsteke, Peter, Brain, Etienne, Vrijaldenhoven, Suzan, Neijenhuis, Peter A, Causeret, Sylvian, Smilde, Tineke J, Viale, Giuseppe, Glas, Annuska M, Delorenzi, Mauro, Sotiriou, Christos, Rubio, Isabel T, Kümmel, Sherko, Zoppoli, Gabriele, Thompson, Alastair M, Matos, Erika, Zaman, Khalil, Hilbers, Florentine, Fumagalli, Debora, Ravdin, Peter, Knox, Susan, Tryfonidis, Konstantinos, Peric, Aleksandra, Meulemans, Bart, Bogaerts, Jan, Cardoso, Fatima, Rutgers, Emiel J T

Volltext

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal ca... von Elshof, Lotte E, Tryfonidis, Konstantinos, Slaets, Leen, van Leeuwen-Stok, A. Elise, Skinner, Victoria P, Dif, Nicolas, Pijnappel, Ruud M, Bijker, Nina, Rutgers, Emiel J.Th, Wesseling, Jelle

Volltext

Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic breast cancer (HER2CLIMB-05, trial in progress) von Hamilton, Erika P., O'Sullivan, Ciara Catherine Maria, Martin, Miguel, Sohn, Joohyuk, Tryfonidis, Konstantinos, Santarpia, Libero, Yang, Shan, Dieras, Veronique C

Volltext

HER2CLIMB-05: Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic breast cancer von Hamilton, Erika P., Martin, Miguel, O'Sullivan, Ciara Catherine, Curigliano, Giuseppe, Sohn, Joohyuk, Tsurutani, Junji, Tryfonidis, Konstantinos, Santarpia, Libero, Yang, Shan, Diéras, Véronique

Volltext

SEER-Medicare study of early-stage triple-negative breast cancer: Real-world treatment patterns, survival, and expenditures 2010 to 2016 von Sieluk, Jan, Haiderali, Amin, Huang, Min, Yang, Lingfeng, Tryfonidis, Konstantinos, Hirshfield, Kim M.

Volltext

Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program von Vermeulen, Marijn A, Slaets, Leen, Cardoso, Fatima, Giordano, Sharon H, Tryfonidis, Konstantinos, van Diest, Paul J, Dijkstra, Nizet H, Schröder, Carolien P, van Asperen, Christi J, Linderholm, Barbro, Benstead, Kim, Foekens, Renee, Martens, John W.M, Bartlett, John M.S, van Deurzen, Carolien H.M

Volltext

Pembrolizumab and chemotherapy in high-risk, early-stage, ER + /HER2 - breast cancer: a randomized phase 3 trial von Cardoso, Fatima, O'Shaughnessy, Joyce, Liu, Zhenzhen, McArthur, Heather, Schmid, Peter, Cortes, Javier, Harbeck, Nadia, Telli, Melinda L, Cescon, David W, Fasching, Peter A, Shao, Zhimin, Loirat, Delphine, Park, Yeon Hee, Fernandez, Manuel Gonzalez, Rubovszky, Gábor, Spring, Laura, Im, Seock-Ah, Hui, Rina, Takano, Toshimi, André, Fabrice, Yasojima, Hiroyuki, Ding, Yu, Jia, Liyi, Karantza, Vassiliki, Tryfonidis, Konstantinos, Bardia, Aditya

Volltext

Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study von Turner, Nicholas C, Balmaña, Judith, Poncet, Coralie, Goulioti, Theodora, Tryfonidis, Konstantinos, Honkoop, Aafke H, Zoppoli, Gabriele, Razis, Evangelia, Johannsson, Oskar T, Colleoni, Marco, Tutt, Andrew N, Audeh, William, Ignatiadis, Michail, Mailliez, Audrey, Trédan, Olivier, Musolino, Antonino, Vuylsteke, Peter, Juan-Fita, Maria Jose, Macpherson, Iain R J, Kaufman, Bella, Manso, Luis, Goldstein, Lori J, Ellard, Susan L, Láng, István, Jen, Kai Yu, Adam, Virginie, Litière, Saskia, Erban, John, Cameron, David A

Volltext